The sale of this item is reserved for health professionals.
Intended for the qualitative detection of a specific antigen of SARS-CoV-2 present in Nasal (Anterior Nares) or nasopharynx
The results are intended to aid in the early diagnosis of SARS-CoV-2 infection in individuals suspected of COVID-19 within the first 6 days of the onset of symptoms
Has a sensitivity of 90.20% for nasal specimens (anterior nares) and 95.8 % for nasopharyngeal specimens
